Type 1 Diabetes Clinical Trials

Explore a Type 1 Diabetes and Insulin Comparison Research Study

Type 1 Diabetes is an autoimmune disorder in which the body’s immune system attacks the insulin-producing beta cells in the pancreas. This results in the body losing its ability to produce insulin, a hormone essential for controlling blood sugar levels. Individuals with Type 1 Diabetes require lifelong insulin therapy to survive. Without insulin, glucose cannot be transported into cells for energy, leading to elevated blood sugar levels and potential complications including kidney disease, nerve damage, vision impairment, and cardiovascular issues.

While insulin therapy is vital, managing Type 1 Diabetes through multiple daily injections can be burdensome, both physically and emotionally. Many individuals struggle to keep their blood sugar within target range, even with diligent care.

Revival Research Institute is currently recruiting participants for a clinical trial in Texas focused on Type 1 Diabetes. This study is exploring a once-weekly insulin regimen as an alternative to the traditional daily injection schedule. Both types of insulin will be used alongside mealtime insulin, and the research aims to evaluate whether the weekly option offers comparable or improved blood sugar control with fewer injections. The goal is to determine if this new therapy can simplify diabetes management without compromising effectiveness.

You may qualify to participate if you:

1. Be at the age of 18 years or older
2. Diagnosed with type 1 diabetes mellitus ≥ 1 year before screening
3. Treated with multiple daily insulin injections (daily basal insulin analogue and bolus insulin analogue regimen) ≥ 6 months before screening
4. HbA1c levels must be between 7.0–10.0% at the time of screening

*Additional Criteria may apply
Your doctor will go over the additional study criteria with you to determine if you qualify. If you qualify and decide to participate in the type 1 diabetes clinical trials in Texas, you will receive all study-related care, free of cost.

*You will be compensated for your time and travel expenses.

*If you think you may be eligible to participate in the paid type 1 diabetes and insulin comparison research studies or would like more information, please enter your information in the form so our research team can determine if you qualify and could contact you about the study.

Get Started: What to Expect?

If you would like to learn more about our type 1 diabetes clinical trials, please fill out the form above. A research representative will contact you to provide more information about the study. If you qualify for the type 1 diabetes clinical trials, you will be invited to our study site for screening. If you qualify after the screenings and choose to participate, you will be asked to sign an informed consent form outlining the criteria and details of the investigational study treatment.

After signing, you may be asked to answer health-related questions and undergo various assessments and tests to determine your eligibility as a clinical trial participant. During the study, participants will be randomly assigned to get either investigational medicine or placebo.

*Participants will receive free-of-cost investigational treatment. If you choose to join our type 1 diabetes clinical trials in Texas, you may also receive study-related care from healthcare professionals.